CIA
BSX icon

Caerus Investment Advisors’s Boston Scientific BSX Stock Holding History

Caerus Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
7,899
+4,140
+110% +$225K 0.11% 179
2026
Q1 		$236K Buy
+3,759
New +$301K 0.1% 208
2025
Q4 		– Sell
-2,532
Closed -$247K – 319
2025
Q3 		$247K Buy
+2,532
New +$262K 0.1% 232

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caerus Investment Advisors's BSX Position: Q2 2026 in Review

Caerus Investment Advisors increased its Boston Scientific (BSX) stake by 110% in Q2 2026, buying an estimated $225K and bringing the position to 7,899 shares worth $337K. The position accounts for 0.11% of the portfolio, ranked #179.

Caerus Investment Advisors first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Caerus Investment Advisors held 7,899 shares of Boston Scientific worth $337K as of Q2 2026.
  • Caerus Investment Advisors bought 4,140 Boston Scientific shares in Q2 2026, an estimated $225K.
  • Boston Scientific made up 0.11% of Caerus Investment Advisors's portfolio in Q2 2026, its #179 holding.
  • Caerus Investment Advisors first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caerus Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.